Archive for the ‘Strategic Plan’ Category

IHIF is a Proud Partner in National Health IT Week

August 21, 2016

This September, IHIF — as a partner in the advancement of health information technology to help improve healthcare —is a Proud Partner in National Health IT Week.  National Health IT Week is the premier event offering all healthcare stakeholders an opportunity to unite under one banner, expressing the benefits that health information technology (IT) brings to U.S. healthcare. “The Value of Health IT.”

Comprehensive health care reform is not possible without system-wide adoption of health information technology, which improves the quality of healthcare delivery, increases patient safety, decreases medical errors, and strengthens the interaction between patients and healthcare providers.

With Meaningful Use now providing the way forward, eligible providers across the country increasingly understand the benefits for themselves and their patients, and are adopting Meaningful Use compliant electronic health records.

Initiated in 2006 by the Healthcare Information and Management Systems Society (HIMSS), National Health IT Week has emerged as a landmark occasion for using health IT as part of the overall solution to improve America’s healthcare as a bipartisan, federally led, market driven initiative.

The Week consists of events across the country, including National Health IT Weekparticipants —vendors, provider organizations, payers, pharmaceutical/biotech companies, government agencies, industry/professional associations, research foundations, and consumer protection groups— all working together to elevate national attention to the advantages of advancing health IT.

View our full list of partners and updates on the Week’s events. Working together with our growing coalition of stakeholders, IHIF is helping to transform healthcare for all.

Ivy Tech Bloomington led development of national educational skill standard for medical device careers

August 9, 2016



August 9, 2016


Contact:  Amanda Billings

Executive Director, Marketing/Communications

Ivy Tech Community College – Bloomington

(812) 330-6222   |


BLOOMINGTON – Ivy Tech Community College’s Bloomington campus led a consortium of 12 other community colleges and 72 medical device industry partners nationwide to develop the nation’s first skill set standards for entry-level medical device jobs in the U.S. The Community College Consortium for Bioscience Credentials (c3bc) published “Medical Device Skill Standards,” a manual of educational guidelines to ensure educators and trainers develop and teach the skills needed in entry level medical device jobs in the U.S. The project was funded by a $15 million dollar grant from the U.S. Department of Labor.


Sengyong Lee, Ph.D., professor and Ivy Tech Bloomington biotechnology program chair, is c3bc’s medical device hub leader. Dr. Lee and his team at Ivy Tech Bloomington led the nationwide collaboration. “The advancement of medical technology and growing health care needs for elderly populations around the globe have accelerated the growth of companies like Cook Medical in recent decades,” Dr. Lee said. “The medical device industry is in need of a continuous pipeline of skilled workers to meet their growth demands. Our partners and educators who developed the skill standards manual hope for a long-term return on investment in the form of graduates from community colleges who will fill those jobs.”


Local employers, including Chapman Lake Instrument Corp., Cook Medical, Cook Polymer Technology, and Boston Scientific Corporation, participated as industry partners. Employers outlined skills needed in entry-level medical device positions, which educators used to create skill standards for teaching and testing students.


Educators nationwide have already begun to use the skill standards manual to create new and revise educational courses, certificates, and degrees to align with industry needs. For example, Ivy Tech Bloomington developed a new medical device quality certificate that counts toward the biotechnology associate degree and leads to a career in the industry. Ivy Tech Bloomington also has a plastics program and regulatory affairs certificate to meet local employer needs.


In addition to publishing the manual, c3bc also developed ‘Courses in a Box’ which educators nationwide can use to develop curriculum. The downloadable, digital materials outline exactly what should be taught, and includes everything a credentialed instructor would need to teach the course online or in person.


“The courses in a box project will be especially valuable to educators and trainers who are new in the field. Of course, the main beneficiaries of the project are the students and trainees who will receive valuable education,” Dr. Lee said.


The c3bc’s Medical Device Skill Standards manual and Courses in a Box are now published and are free and available to download. The standards manual can be found online at and the Courses in a Box can be found at


For information about Bloomington programs in medical device manufacturing, plastics, and biotechnology, visit and click Bloomington. Fall classes begin August 22 but students should enroll by August 12 in order to be prepared on the first day of classes. To enroll, visit, stop into Ivy Tech Bloomington located at 200 Daniels Way, or call (812) 330-6013.


About Ivy Tech Community College
Ivy Tech Community College ( is the state’s largest public postsecondary institution and the nation’s largest singly accredited statewide community college system.  Ivy Tech has campuses throughout Indiana. It serves as the state’s engine of workforce development, offering affordable degree programs and training that are aligned with the needs of its community along with courses and programs that transfer to other colleges and universities in Indiana. It is accredited by the Higher Learning Commission and a member of the North Central Association.




Interview contacts:


Dr. Sengyong Lee


Chris Kilander

Global Product Manager/Team Leader – Peripheral Intervention

Cook Incorporated

750 Daniels Way

Bloomington, IN 47404

1-800-468-1379 ext. 10-1978

Mobile: 812-322-8097


Kathy Heuer,

Executive Director, Indiana Medical Device Manufacturing Council, Inc.

Kathy Heuer

Executive Director, IMDMC, Inc.

PO Box 441385

Indianapolis, IN 46244

(260) 609-2802


IHIF Announces Legislators of the Year

May 16, 2016

Recognizes those making significant policy impact on the state’s health science sector

Contact: Kristin Jones, President and CEO
Indiana Health Industry Forum or 317-686-0994

INDIANAPOLIS, IN (May 16, 2016) — In conjunction with its 2016 Annual Meeting, the Indiana Health Industry Forum (IHIF) recognized U.S. Representative Larry Bucshon, M.D., and State Senator Patricia Miller as the IHIF 2016 Legislators of the Year.  “Each year we recognize federal and state legislators who have demonstrated a commitment to excellence in public health policy and service to Indiana’s health science business community”, said Kristin Jones, President and CEO of IHIF.  “This year we are so pleased to be able to recognize both Representative Bucshon for his work and leadership on the Congressional 21st Century Cures Initiative and Senator Miller for her dedication to health issues and 30 years of public service”.


Prior to being elected to Congress, Representative Bucshon spent his career specializing in cardiothoracic surgery and has performed hundreds of heart surgeries.  As one of only a few practicing physicians in Congress his experience with all aspects of health care delivery afford him unique insight and perspective on efforts to improve patient care and seek value across the health care spectrum.  He has been an educated voice of opposition to a proposed CMS rule that would implement a new Medicare Part B drug payment model that would negatively affect patient access to essential medication and treatment therapies.   He has also been a leader in the fight against opioid abuse, working with Representative Paul Tonko (D-NY) to introduce, “The Opioid Use Disorder Treatment Expansion and Modernization Act”.


Senator Patricia Miller announced earlier this year that she would be retiring from the state legislature after more than 30 years.  Her outstanding efforts as Chair of the Senate Committee on Health and Provider Services have led to policies that have touched and improved the lives of countless Hoosiers. Her commitment to common sense care and high regard for patient dignity are well reflected in her legislative record.


“We are proud that Indiana has been so involved, informed, and well represented”, said Jones “and we are pleased to be able to recognize the contributions of Rep. Bucshon and Senator Miller”.   Previous recipients of IHIF’s Legislative Award include: State Representative. Ed Clere (2014), State Senator Brandt Hershman (2014), and U.S. Representative Susan W. Brooks (IN-5) (2015).

Rep. Larry Bucshon Official Photo
U.S. Rep. Larry Bucshon, M.D. (IN-8th)
Member of the House Energy &
Commerce Committee


Senator Patricia Miller (District 32)
Assistant President Pro-Tempore

About IHIF

The Indiana Health Industry Forum (IHIF) is a statewide trade association representing members of Indiana’s health science business community.  The diverse members of IHIF generate the collective voice of the state’s health and life science industry.  Our mission is to connect key stakeholders to: enhance business networks, advocate for member interests, develop workforce skills, and provide strategic vision in the interest of growing the state’s health industry economy and reputation.  For more information and to become a member, please visit




February 2016 Life Science Lunch

February 16, 2016

Clinical Trials from a Study Site Perspective

The conduct of clinical research requires effective working relationships between the study sites that execute clinical trials and the sponsors that design the trials and provide product for testing. With much riding on study outcomes, understanding what happens behind the scenes may help you design more effective trials.  This month’s discussion will explore some of the bigger technical challenges to running a clinical research site, including:
•    Types of clinical trials, sponsors and study sites
•    Staffing/Workforce requirements,  needs, and challenges
•    Managing study site and sponsor expectations
•    Role of an IRB
•    Subject recruitment, screening, informed consent and enrollment
•    Managing costs


Deborah Pollack-Milgate, Partner

Barnes & Thornburg, LLP


Diana Caldwell

President and Founder

Pearl Pathways

Jenna Sallee

Executive Director

Orthopedic Research Foundation, Inc.

Dr. Scott Denne


CTSI Clinical Research Center at IUPUI

About the Series

The Indiana Health Industry Forum and Barnes & Thornburg LLP partner to present a monthly seminar series on critical issues in life science. Each month, at lunch, a policymaker or a panel in the field of life science will be available to answer questions concerning the major challenges and opportunities in the life science industry. We hope you will join us.

There is no charge to attend, but please register so we know how many lunches to order. Please see registration page for details. Some of the discussion questions will be submitted to the speakers in advance.

For information on upcoming programs, please visit the Life Science Lunch website –

Supporting Materials Mentioned in Today’s Discussion

New “Time Is Precious” Video from BIO


Learn more at TimeIsPrecious.Life

“Research in Your Backyard: Developing Cures, Creating Jobs” PhRMA Report on Clinical Research in Indiana

IHIF 2016 Legislative Breakfast and Industry Briefing

January 18, 2016


An IHIF Signature Event

Presented by:

 Print     HWFH new logo     IMDMC 2013 Logo

You are Invited!

January 27, 2016


Downtown Indianapolis Hilton Hotel

120 W. Market Street

Monument Hall (Lower Level)


With Featured Speakers

Lt. Governor Sue Ellspermann


Rep. Ed Clere, House Public Health Committee

Due to a schedule change, Senator Pat Miller will be unable to join us for the program.  We are pleased to announce that Lt. Governor Sue Ellsperman will be with us to share her thoughts on the direction of the life science industry in Indiana.  Rep. Ed Clere will provide an assessment of the 2016 Legislative Session with special regard for public health matters.

Registration 7:15 am

Program 7:30 – 8:30 am

Welcome and Introduction

Kristin Jones, IHIF

  IMDMC Legislative Update

Kathy Heuer, Executive Director

“The Value of Medicines”

Saiza Elayda, PhRMA

The Indiana Health Industry Forum is a state-based trade association for members of Indiana’s health and life science manufacturing community.  The goal of the annual legislative breakfast briefing is to educate and engage IHIF members on Federal and State public policy issues and activities.  The event is open to member companies of IHIF, the Indiana Medical Device Manufacturers Council (IMDMC), the Hoosiers Work for Health/PhRMA task force, and all members of the Indiana General Assembly.  There is no charge to attend but please register.  For more information on IHIF, please visit


Please register here to attend the breakfast briefing

IHIF Welcomes Mindray for First Discovery Days Program

January 7, 2016


Momentum Logo June 2014

Discovery Days

February 17-18, 2016

Mindray logo


The Indiana Health Industry Forum is pleased to announce that we have finalized dates for a company visit to Indiana by Mindray.   IHIF will be hosting company representatives here in Indianapolis on February 17th -18th for our first Discovery Days program!  Mindray representatives are interested in meeting Indiana businesses working in two areas: 1) in-vitro diagnostics and 2) assistive technologies, including health IT applications.  They are interested in meeting with both companies with established products looking to expand their market into China as well as identifying novel technologies that could use a developmental partner.   Mindray offers investment capital, assistance with CFDA approval, and joint venture opportunities.

About Mindray Medical International

Mindray was founded in 1991 in Shenzhen, China, with a mission to deliver high-quality, competitively priced medical devices to make healthcare more accessible and affordable around the world. Over the last 17 years, we have become a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence. We are expanding our distribution network, sales and sales support staff to bring our products closer to end users. We currently have 29 local sales and service offices in China, as well as sales and service subsidiaries in Amsterdam, Istanbul, London, Mexico City, Moscow, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver.   For more information, please visit

Apply to meet

If you have technologies or know of companies that may be interested in meeting with Mindray’s technology development representatives, please let us know!  IHIF is working to identify a pool of potential companies/technologies and then, working with Mindray, we’ll put together a short list of invitees to a 1-on-1 meeting with them here in Indianapolis.   Please submit a short (1 page) description of the company/technology to get things started.    Please submit descriptions to IHIF at   We will begin notifying accepted applicants by January 20th.

IHIF and Lodestone Insights Partner on New Member Benefit Program

November 1, 2015
ihif lodescore logo
The Indiana Health Industry Forum and Lodestone Insights are pleased to announce a partnership for the benefit of IHIF members.
Lodestone Insights ( is the world’s only human curated and organized database of information and activities happening at conferences and symposia. We are tracking thousands of conferences in the healthcare, pharmaceuticals, science, diabetes, oncology, immunology, neuroscience, and technology sectors. Our clients leverage our Lodestone Insights products and services to make more informed strategic decisions.
Through Lodescore and our other products, managers, business development, competitive intelligence, due diligence, sales, marketing, and brand professionals are able to tap millions of points of data to:
  • Track their own brand presence and investments
  • Monitor thought leaders
  • Find new customers and partners
  • Pro-actively plan boots-on-the-ground conference strategies/tactics
  • Surface hot topics and trends in the market
  • Gain insights on their competitors
Lodescore is the first standardized scoring tool to shop and compare conferences. Save time and money and pick the right conferences to attend, speak, exhibit, and sponsor. Lodescore actively tracks over 4,000 conferences across the health science space and provides the details and analytics to help you make informed decisions on where to best spend your limited time, energy, and resources.
A free Lodescore demo is available on-line and there are multiple plan options to fit your needs and budget. IHIF Members are eligible for a 10% discount on current Lodestone Insight product rates.  
To request a member discount promo code, please contact IHIF.

Boehringer Ingelheim Day with MassBio

September 23, 2015

Boehringer Ingelheim Day with MassBio

2:00 – 7:30pm

MassBio and Catalyst restaurant at 300 Technology Square, Cambridge, MA 02139

October 8th, 2015


The Indiana Health Industry Forum has been invited to submit member profiles for consideration in the Boehringer Ingelheim Pharma Days program.  This event will be held in Boston, October 8th and is organized by MassBio – IHIF’s counterpart organization in Massachusetts.  If you would like to be considered for a one-on-one meeting with Boehringer Ingelheim, please submit a one-pager describing your program of interest to Kristin Jones at IHIF ( by September 30th.  Please do not disclose confidential information. If selected, you must be able to travel to Boston on October 8th to participate in the meetings.


Please join us on Thursday, October 8th, 2015 for a private meeting and reception with a select group of MassBio members and senior leaders from Boehringer Ingelheim.

Boehringer Ingelheim will provide an overview of its Research & Development organization, Venture fund, therapeutic areas of interest and models for early and late stage licensing partnerships. There will be an opportunity to request one–to-one meetings. A poster competition and pitch contest will take place and a networking reception will follow the program. An innovation prize will be awarded to the winning start-up from the pitch contest at the reception.

One-on-one meetings may be requested by participants.

Boehringer Ingelheim will have teams within the following areas participating in one-on-one meetings: CNS, Oncology, Cardiometabolic, Immunology, Respiratory, Hearing loss, Microbiome, Regenerative medicine and Gene medicine.  For more details, see list below.


2:00 – 3:00pm               Registration and Poster presentation vote for Innovation Prize

Attendees will receive Massbio Dollars to invest into the top 3 most innovative technologies presented.


3:00 – 3:05pm               Welcome by MassBio Robert K. Coughlin, President and CEO at MassBio


3:05 – 3:30pm            Boehringer Ingelheim Partnering – Working Together for Better Health

  • Paola Casarosa, Corp VP, Business Development & Licensing/ Prescription Medicines


3:30 – 4:00pm            Discovery Research and External Innovation

  • Clive Wood, Corp Senior VP, Discovery Research


4:00 – 4:30pm            Boehringer Ingelheim Corporate Venture Fund

  • Frank Kalkbrenner, VP, Head of the Boehringer Ingelheim Venture Fund


4:30 – 5:00pm               Innovation Prize pitches and judging


5:00 – 5:30pm               Boehringer Ingelheim closing remarks and Q&A


5:30 –7:00pm                Reception – Catalyst
Innovation Prize winner will be announced at the reception


This event, part of the MassBio Pharma Day Series, will provide a great opportunity to network with Boehringer Ingelheim licensing and therapeutic area leaders and learn how a biopharmaceutical company evaluates external research and approaches licensing and partnerships.


Current Areas of Interest:


    • Central Nervous System
  • Alzheimer’s disease
  • Schizophrenia (focus: negative symptoms and/or cognitive impairment)
  • Depression (focus: treatment-resistant depression)
  • Impulse control disorders

Out of scope: Monoamine uptake inhibitors or monoamine receptor modulators, Compounds with undefined mechanism of action

    • Oncology
  • For clinical stage opportunities: Focus on lung cancer and haematology – irrespective of the MoA
  • Up to IND-ready stage:
  • Cancer cell -directed therapies
    • Growth signaling
    • Apoptosis regulation
    • Epigenetic regulation
    • Protein homeostasis
    • Additional areas of focus will emerge from scientific breakthroughs in cancer biology (e.g. genome integrity, splicing, protein translation, stem cell / developmental pathways, miRNAs)
  • Immune cell -directed therapies
    • Immune cell re-activation
    • Immune cell re-direction
    • Immune cell priming
    • Increased focus in the future will be on lymphocyte trafficking


  • Immunology
    • Crohn’s disease and ulcerative colitis
    • Systemic lupus erythematosus (including lupus nephritis)
    • Rheumatologic disorders such as RA (limited to mechanisms that show superior efficacy compared to current standard of care) and spondyloarthritis
    • Systemic sclerosis-scleroderma

Out of Scope: Microbial therapeutics and Gene therapy


  • Cardiometabolic
    • Chronic Kidney Diseases and Diabetic Nephropathy
    • Diabetic Retinopathy
    • NASH (Nonalcoholic steatohepatitis) and liver fibrosis
    • Obesity (CV-benefit and patient relevant weight loss >10%)
    • Type 2 Diabetes (evidence for disease modification, CV-risk reduction and/or significant weight reduction)


  • Respiratory
    • Chronic Obstructive Pulmonary Disease
    • Asthma
    • Interstitial Pulmonary Fibrosis
    • Cystic Fibrosis
    • Acute Lung Injury or Acute Respiratory Distress Syndrome


  • Research Beyond Borders
  • Microbiome:
    • Novel bacteria/bacterial products and their causal role in human health & disease (esp. related to autoimmune, CNS, oncology  and cardiometabolic disorders)
    • Microbiome triggers which impact host immune/inflammatory response & barrier function Depression (focus: treatment-resistant depression)
    • Elucidation of associated pathways & discrete targets (both host & microbiome-derived) for therapeutic intervention
  • Regenerative Medicine:
    • Molecular understanding of mechanisms involved in tissue degeneration
    • New targets or methods for identifying targets that are implicated in the mobilization and/or differentiation of endogenous stem cells/progenitor cells
    • Approaches that may modulate muscle/bone/cartilage degeneration, and/or neurodegeneration
  • Gene Therapy:
    • Rare diseases with high unmet medical need as entry, enabling BI to become a leader in the field; including proprietary assets available for potential partnering
    • Technology platform development, focusing on inducible system for regulatable expression of therapeutic products in the context of AAVs, ensuring applicability of gene therapies in nonlife-threatening diseases
  • Hearing Loss:
    • Understanding of mechanisms involved in hearing loss and approaches with potential to restore hearing or reduce loss
  • Age-related, as well as noise and drug-induced hearing loss




Boehringer Ingelheim Attendees:


Dr. Paola Casarosa, Corp. VP, Bus. Dev. & Licensing/Prescription Medicines

Dr. Monica Cheng, Global Licensing, Cardiometabolic Diseases, Bus. Dev. & Licensing/Prescription Medicines

Dr. Laurie Churchill, Global Head Immunology, Bus. Dev. & Licensing/Prescription Medicines

Dr. Henri Doods, VP, Research Beyond Borders

Dr. Jay Fine, Vice President & Global Therapeutic Area Head Immunology and Respiratory Diseases Research

Dr. Christine Grygon, Executive Director, Bus. Dev. & Licensing/Prescription Medicines

Dr. Martin Heidecker, Head of Venture Fund USA

Dr. Jullian Jones, Global Licensing, Oncology

Dr. Frank Kalkbrenner, VP, Venture Fund

Dr. Cyrille Kuhn, Executive Director, Head of Research Beyond Borders

Dr. Michael Mark, Global Head CardioMetabolic Diseases Research

Dr. Klaus Mendla, Global Head CNS, Bus. Dev. & Licensing/Prescription Medicines

Mr. Imran Nasrullah, Innovation Sourcing, Bus. Dev. & Licensing/Prescription Medicines

Dr. Chad Nivens, Global Head Respiratory, Bus. Dev. & Licensing/Prescription Medicines

Mr. Andrew Owenson, Corp. SVP, Therapeutic Area Head Respiratory

Dr. Michel Pairet, Corp. SVP, R&D non-clinical

Dr. Glyn Parkin, Corp. SVP, Therapeutic Area Head Cardiometabolic Diseases

Dr. Mark Pearson, VP, New Therapeutics Concept Discovery

Dr. Jan Poth, Therapeutic Area Head Immunology & Vice President Marketing, Pipeline Products

Mr. Ralph Mark, Director, External Partnerships and Financial Strategy

Dr. Juergen Reess, Therapeutic Area Head CNS

Dr. Oliver Reuss, Head of Business Model & HealthCare Innovation

Dr. Ioannis Sapountzis, Global Head Oncology, Bus. Dev. & Licensing/Prescription Medicines

Prof. Dr. Gerd Schnorrenberg, Senior Executive Advisor, R&D non-clinical

Dr. Margrit Schwarz, VP, Cardiometabolic Diseases Research

Dr. Peter Seither, Senior Manager, Scientific Collaborations

Dr. Bernd Sommer, Head of CNS Research

Dr. Georg van Husen, Therapeutic Area Head Cardiovascular

Dr. Clive Wood, Corp. SVP, Discovery Research

Dr. Johannes Zanzinger, Global Head Cardiometabolic Diseases, Bus. Dev. & Licensing/Prescription Medicines


IHIF Announces Trade Mission to Zhejiang International Health Services Expo

September 21, 2015
Join IHIF and members of Indiana’s medical equipment sector on a trade mission to participate in the Zhejiang International Health Services Expoin Hangzhou, China, November 12-14 and participate in pre-arranged meetings with potential partners in the region.
About the Expo
Zhejiang World Trade Exhibition Center, Hangzhou
November 12-14, 2015
Expecting 350+ exhibitors and 20,000 attendees
  • Exhibitors include: non-government investment to health services, PPP model medical facilities, commercial health insurance plans, elder-care, Traditional Chinese Medicine (TCM) healthcare, tourism,sports and culture related healthcare projects.
  • Health information and products exhibition includes: all kinds of wearable health devices,telemedicine systems, portable medical equipment & supplies, and electronic medical devices, etc.
  • Health services industry and health services pillar industry products exhibition includes: newly developed pharmaceuticals,medical equipment and devices, Zhejiang featured TCM products, healthy food, health sport accessories and elder-care products, etc.
About the Mission
Through IHIF’s exclusive partnership with the Zhejiang Health Services Promotion Council (HSP), IHIF members will receive exhibition space in the IHIF booth, pre-arranged meetings with potential regional partners, and an opportunity to network with the 500+ members of the HSP.
Mission Participation Fee: $1,500* – payable to Indiana Health Industry Forum
* Does not include airfare/lodging/meals
* IHIF has reserved a block of rooms at the Hangzhou Hyatt available to mission participants
* Catalog participation option: $500
Mission Agenda:
November 9/10 – Depart Indiana/Arrive in Hangzhou, China
November 11 – Meetings and booth set-up
November 12-14 – Zhejiang International Health Services Expo
Private meetings arranged by HSP
November 15 – Return to Indiana
(Optional) Additional meetings may arranged Monday-Tuesday, November 16-17, through Pacific World Trade.  Additional fees may apply.

Registration deadline and requirements:

Please respond by October 5 – provide names of attendees and indicate whether you will be shipping products for display in the booth.  Participants will need to have business cards and materials in Mandarin.  IHIF/PWT can assist with translation and printing of brochures and cards (fees may apply).

For more information or to register, please contact:

Kristin Jones, IHIF
Learn more about IHIF’s Partnership with the Zhejiang Health Services Promotion Council

IHIF Announces MOMENTUM Program Manager

August 17, 2015

Advances Regional Partnership with Kentucky Counterpart

Momentum Logo June 2014

August 17, 2015 (INDIANAPOLIS, IN AND LOUISVILLE, KY) – The Indiana Health Industry Forum (IHIF) is pleased to announce that Andrew Steen will be serving as the Program Manager, Regional Innovation Services in a joint role with the Kentucky Life Sciences Council (KLSC), IHIF’s counterpart organization.  Steen will manage the first cycle of the MOMENTUM:Team Mentorship program, the leading piece of IHIF’s newly introduced mentorship initiative.  He will also be responsible for development of a one-year work plan for a joint state initiative to leverage the region’s life science academic, entrepreneurial, and commercial resources.

Steen has spent the past 15 years working within an academic medical center, principally focused on life science commercialization efforts. He was most recently the Interim President and CEO of MetaCyte Business Lab LLC, a subsidiary of the University of Louisville Foundation, Inc. During his time at MetaCyte Andy worked with scientists and clinicians to create companies, often functioning as part of the founding entrepreneurial team. Andy has built a significant industry network which he is able to leverage on behalf of MOMENTUM participants.

“We are incredibly lucky to have someone with Andy’s extensive background and experience leading this Cycle of MOMENTUM”, said Kristin Jones President and CEO of the Indiana Health Industry Forum.  “Having him on board with the program puts our mentors and entrepreneurs ahead of the game.  We are also delighted to be able to partner with the KLSC to build out a more cohesive regional strategy to better leverage and support entrepreneurs, academia, and industry.  MOMENTUM fits well with this broader strategy and this partnership should serve as a model to include other states as we go forward”.

Dr. Kyle Keeney, President and CEO of the KLSC said, ”this initiative is all about making it easier to connect ideas, people, and resources in the most efficient and effective ways possible.  The Kentucky-Indiana relationship is strong and both states can only benefit from greater knowledge of each other’s assets.  Andy Steen is now uniquely positioned to bring that vision to fruition. We couldn’t be more pleased to be working with IHIF on building a system that supports entrepreneurs in both states”.

The first 10-week Cycle of MOMENTUM:Team Mentorship will begin in September 2015 and features mentee companies B2S Labs, Sintact Medical Systems, and Reclaim Rx.  The program is being supported by CTSI, Barnes & Thornburg, The Indiana Office of Small Business and Entrepreneurship (OSBE)/ISBDC and the Gayle and Bill Cook Center for Entrepreneurship at Ivy Tech, Bloomington.  If you would like to learn more about becoming a MOMENTUM:Mentor or program sponsor, please visit


About IHIF

The Indiana Health Industry Forum (IHIF) is a statewide trade association representing members of Indiana’s health science business community.  The diverse members of IHIF generate the collective voice of the state’s health and life science industry.  Our mission is to connect key stakeholders to: enhance business networks, advocate for member interests, develop workforce skills, and provide strategic vision in the interest of growing the state’s health industry economy and reputation.  For more information and to become a member, please visit

About KLSC

The mission of the Kentucky Life Sciences Council is to provide advocacy and commercialization support that promote the life science community in Kentucky. For more information please see


MOMENTUM:Mentor Networks is a comprehensive set of programs designed to support Indiana’s health science sector and better tie industry, our research community, and our entrepreneurs together.  The programs will encourage earlier interaction between industry and investigators, provide earlier feedback on ideas and company development, and encourage later stage entrepreneurial growth and development.  To learn more, please visit